News & Trends - Medical Technology

$18.8M funding boost for 21 new MedTech innovations across Australia

Health Industry Hub | July 22, 2020 |
[Total: 1    Average: 5/5]

MedTech News: 21 medical technology projects have received funding of $18.8 million through the third round of the BioMedTech Horizons (BMTH) program, an initiative of the Medical Research Future Fund (MRFF) operated by MTPConnect. 

The funding, announced by the Minister for Health, The Hon. Greg Hunt MP, is predominantly for digital health innovations and has attracted an additional $21.3 million in industry contributions which means a total of $40.1 million is flowing into the healthtech sector.

From the 21 selected projects, patients of the future are set to benefit from new research into treatments and diagnostics for conditions such as cancer, epilepsy, stroke, paralysis, Irritable Bowel Syndrome, brain injuries, back pain and chronic middle ear disease.

Through the BMTH program and the MRFF we are backing innovation and technological advancements in areas such as digital health solutions, medical devices, precision and regenerative medicine supported by advanced manufacturing and clinical trials with a vision of better health outcomes globally.  

Building home-grown translational and commercialisation capacity means boosting our knowledge economy and creating new products, jobs and potential exports. This is particularly important now considering the hit that our sector has taken dealing with the impact of COVID-19 pandemic and lockdown.

MedTech Funding Recipients

Anatomics Pty Ltd, Victoria, is developing digitally enabled skullcaps to monitor brain swelling in craniectomy patients to optimise timing of skull reconstruction surgery.

Anisop Holdings Pty Ltd, New South Wales, is developing a nano-optimised surface to prevent orthopaedic and dental implant infections.

Apollo Medical Imaging Technology Pty Ltd, Victoria, is developing an Artificial Intelligence-based clinical decision support software for guided acute stroke therapy.

Artrya Pty Ltd, Western Australia, is developing Artificial Intelligence methods for evaluating cardiac CT angiography and high-risk imaging biomarkers.

Atmo Biosciences Pty Ltd, Victoria, is developing an application of Atmo ingestible gas sensing capsule to diagnose Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO).

Bionic Vision Technologies Pty LtdVictoria, is developing an implantable vision system and algorithm in their Bionic Eye Generation 3 device to restore functional vision for blind patients.

Carbon Cybernetics, Victoria, is developing a high-resolution cortical recording of the brain for the prediction and prevention of epileptic seizures.

Ear Science Institute Australia, Western Australia, is advancing the commercialisation of its ClearDrum device, which is an acoustically-optimised silk fibroin implant for the treatment of chronic middle ear disease.

Ferronova Pty Ltd, South Australia, is working to improve colorectal cancer outcomes with hybrid cancer tracers.

HemideinaVictoria, is developing a miniature, low-energy wireless power and data transmission system for implantable medical devices.

Inventia Life Science Pty Ltd, New South Wales, is developing a 3D bioprinting system for intraoperative skin regeneration.

Merunova Pty Ltd, New South Wales, is developing an augmented digital re-construction and re-visualisation of spine MRI for the personalised diagnosis of back pain.

Miniprobes Pty Ltd, South Australia, is developing a smart brain biopsy needle for faster, safer neurosurgery.

Neuromersiv Pty Ltd, New South Wales, is advancing the commercialisation of its hand and arm wearable device for use with the Neuromersiv virtual reality rehabilitation system.

Northern Research Pty Ltd, New South Wales, is advancing the commercialisation of its PulseVAD pulsatile rotary blood pump that is designed to treat patients suffering from a form of Congestive Heart Failure (CHF) for which, at present, there is no effective treatment.

OncoRes Medical Pty Ltd, Western Australia, is developing compact wireless technology for improvement in the accuracy during breast conserving surgery.

Optiscan Pty Ltd, Victoria, is developing its non-invasive confocal endomicroscopy system to enhance oral cancer screening and surgical margin assessment.

Seer, Victoria, is developing personalised epilepsy treatment via mobile and wearable monitoring.

Synchron Australia Pty Ltd, Victoria, is advancing the commercialisation of its Stentrode; a minimally-invasive brain-computer interface being designed to enable people with paralysis to restore functional independence by engaging in activities of daily living such as email communication, text messaging and online shopping, by controlling apps and external devices through thought alone, and without requiring open brain surgery.

VenstraMedical Pty Ltd, New South Wales, is enhancing the development of a transcatheter blood pump system for Cardiogenic Shock and Hemodynamically Compromised patients.

Zip Diagnostics, Victoria, is establishing domestic capabilities for combined R&D and manufacture of point-of-care diagnostics.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - State first heart procedure with non-invasive technology most commonly used to combat cancer

State first heart procedure with non-invasive technology most commonly used to combat cancer

Health Industry Hub | August 4, 2020 |

MedTech News: A team of cardiologists and radiation oncologists from Fiona Stanley Hospital (FSH) and GenesisCare, have become the first […]

More


News & Trends - Pharmaceuticals

Pharma News - Medicines Australia calls for a focus in planning Australia's future in health

Medicines Australia calls for a focus in planning Australia’s future in health

Health Industry Hub | August 4, 2020 |

Pharma News: Medicines Australia Chief Executive Officer, Elizabeth de Somer has urged a focus on planning for the future – […]

More


News & Trends - Medical Technology

MedTech News - Australian-first procedure for chronic pain sufferers

Australian-first procedure for chronic pain sufferers

Health Industry Hub | August 3, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trendsmenu →Medical Technology’ sub-menu.

More


News & Trends - Pharmaceuticals

Pharma News - New PBS listings in lung cancer, epilepsy and ovarian cancer – AstraZeneca, Roche, Pfizer and Emerge Health

New PBS listings in lung cancer, epilepsy and ovarian cancer – AstraZeneca, Roche, Pfizer and Emerge Health

Health Industry Hub | August 3, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trendsmenu →Pharmaceuticals’ sub-menu.

More